Dolby Laboratories, Inc.
DLB
$65.27
$1.081.68%
NYSE
| 06/26/2026 | 03/27/2026 | 12/26/2025 | 09/26/2025 | 06/27/2025 | |
|---|---|---|---|---|---|
| Net Income | -69.87% | 77.99% | 8.10% | 7.08% | -49.81% |
| Total Depreciation and Amortization | -6.61% | 0.12% | 9.11% | 0.73% | -0.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -45.74% | 37.26% | -48.92% | 106.46% | -12.58% |
| Change in Net Operating Assets | 225.60% | -27.48% | -364.50% | 62.39% | -230.40% |
| Cash from Operations | 81.03% | 68.81% | -55.39% | 81.46% | -61.30% |
| Capital Expenditure | -65.43% | -95.81% | 71.51% | -152.71% | 6.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 114.04% | -730.43% | 203.62% | -- | -100.00% |
| Cash from Investing | 78.76% | -3,801.77% | 105.68% | -240.88% | -124.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 803.08% | -92.70% | 184.15% | -60.05% | 216.54% |
| Repurchase of Common Stock | 0.21% | 34.76% | -172.90% | 9.98% | -12.03% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.02% | 0.01% | -8.71% | 0.14% | 0.62% |
| Other Financing Activities | 4.47% | -2.19% | -37.44% | 14.96% | -94.19% |
| Cash from Financing | 8.87% | 18.02% | -90.20% | -5.46% | 6.37% |
| Foreign Exchange rate Adjustments | -423.26% | -5,920.00% | 92.54% | -101.18% | 106.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 221.06% | 18.29% | -278.81% | 491.40% | -95.51% |